Investigating optimal β‐cell‐preserving treatment in latent autoimmune diabetes in adults: Results from a 21‐month randomized trial

Autor:	Ingrid Hals, Marianne Catharina Astor, Nina Reimers, Karin Filipsson, Anneli Björklund, Zuheng Ma, Hanne Fiskvik Fleiner, Valdemar Grill
Rok vydání:	2019
Předmět:	Adult Male medicine.medical_specialty Randomization Endocrinology Diabetes and Metabolism medicine.medical_treatment Autoimmunity 030209 endocrinology & metabolism 030204 cardiovascular system & hematology medicine.disease_cause law.invention 03 medical and health sciences 0302 clinical medicine Endocrinology Randomized controlled trial law Insulin-Secreting Cells Internal medicine Diabetes mellitus Internal Medicine Humans Hypoglycemic Agents Insulin Medicine Latent Autoimmune Diabetes in Adults Aged Dipeptidyl-Peptidase IV Inhibitors business.industry Sitagliptin Phosphate Middle Aged medicine.disease Sitagliptin Population study Female business Body mass index medicine.drug
Zdroj:	Diabetes, obesity and metabolism
ISSN:	1463-1326 1462-8902
DOI:	10.1111/dom.13797
Popis:	Aims To compare outcomes of glucagon‐stimulated C‐peptide tests (GSCTs) in people with latent autoimmune diabetes in adults (LADA) after a 21‐month intervention with either insulin or the dipeptidyl peptidase‐4 inhibitor sitagliptin. Research design and methods We included 64 glutamic acid decarboxylase (GAD) antibody‐positive individuals, who were diagnosed with diabetes
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a542cd81b8027106e2a6f6fdb6fec03 https://doi.org/10.1111/dom.13797 Zobrazit plný text záznamu Plný text